About us

Cadila Pharmaceuticals Sweden AB located at Karolinska Institutet Science Park, Solna is a wholly-owned subsidiary of Cadila Pharmaceuticals Limited, India.

Over the last six decades, the company has been developing, manufacturing and selling pharmaceutical products in over eighty-five countries around the world

What we offer

Our product basket includes branded and generic formulations covering more than 45 therapeutic segments, biotechnology products, plant tissue culture and more than 38 APIs and intermediates. In the services realm, our offering includes Pre-Clinical and Clinical Research as well as Contract Manufacturing

Swedish Research partners

We have scientific collaborations with leading Swedish companies for preventing in-patient infections and development of novel treatment for specific and acute infections, for developing Antibiotic Resistant Breakers and innovative treatment in inflammation and pain management.


The Swedish office has been set up to ensure success of ongoing and future collaborations between Swedish companies and institutions, and our Indian organization. We encourage regional researchers and companies to get in touch with us to discuss potential collaborations or our service offerings
address_icon Karolinska Institutet Science Park, Tomtebodavägen 23a, 171 65 Solna, Sweden mail_icon info@cadilasweden.se contact icon +46 8 524 820 53
To know more visit our corporate website
Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals